Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
12/1998
12/02/1998EP0881292A2 Streptocococcus pneumoniae peptide release factor
12/02/1998EP0881289A2 Novel 7TM receptor (H2CAA71)
12/02/1998EP0881224A1 5-HT1A and 5-HT1D alpha antagonists
12/02/1998EP0880964A2 Aldose reductase inhibition in preventing or reversing diabetic cardiomyopathy
12/02/1998EP0880526A1 Heterocycle-condensed morphinoid derivatives (ii)
12/02/1998EP0880523A1 Pyrazolopyrimidines as crf receptor antagonists
12/02/1998EP0880517A1 Quinazoline compounds
12/02/1998EP0880511A1 Integrin receptor antagonists
12/02/1998EP0880502A1 Aminoheterocyclic derivatives as antithrombotic or anticoagulant agents
12/02/1998EP0752875A4 Glioblastoma-derived angiogenesis inhibiting factor
12/02/1998EP0743953B1 Diastereomeric pure trifluoromethyl ketone peptide derivatives as inhibitors of human leukocyte elastase
12/02/1998CN1200720A Carboxylic acid derivatives, their prepn. and their use
12/02/1998CN1200670A Pharmaceutical compositions contg. hydroximic acid derivatives
12/02/1998CN1200374A Vitronectin receptor antagonists, their prepn. and their use
12/02/1998CN1200373A Vitronectin receptor antagonists, their prepn. and use
12/02/1998CN1200269A Medicine for treating hypertensional sickness
12/02/1998CN1040985C Method for prepn. of benzo-aza-tropilidene compound
12/02/1998CN1040982C Method for preparing pyranoquinoline and salts thereof
12/02/1998CA2230963A1 A human 7-tm receptor similar to murine frizzled-6 gene
12/01/1998US5844092 Human TRK receptors and neurotrophic factor inhibitors
12/01/1998US5844091 Antibody having binding specificity for human ouabain
12/01/1998US5844084 Chemokine expressed in inflamed adenoid
12/01/1998US5843997 Excitatory amino acid receptor antagonists
12/01/1998US5843996 Intravenous magnesium gluconate for treatment of conditions caused by excessive oxidative stress due to free radical distribution
12/01/1998US5843994 Compositions and methods for treating and preventing pathologies including cancer
12/01/1998US5843988 Cyclopropachromencarboxylic acid derivatives
12/01/1998US5843984 Sulfated benzothiophene derivatives, methods of use and formulations containing same
12/01/1998US5843983 Diphenylethane compounds containing a saturated heterocyclic group, their preparation, and their therapeutic use
12/01/1998US5843976 Methods for lowering serum cholesterol and inhibiting smooth muscle cell proliferation, restenosis, endometriosis, and uterine fibroid disease
12/01/1998US5843973 Thiazolidinone compounds and composition for angina pectoris comprising the compounds as an active ingredient
12/01/1998US5843971 1, 1-BIS (heteroazolyl) alkane derivatives and their use as neuroprotective agents
12/01/1998US5843963 Benzothiophene compounds, intermediates, processes, compositions, and methods
12/01/1998US5843956 Substituted N-arylmethyl and heterocyclylmethyl-1H-pyrazolo (3,4-b) quinolin-4-amines and compositions and methods of use thereof
12/01/1998US5843935 Protein kinase C inhibitors
12/01/1998US5843933 11β-aryl-4-estrenes, process for their production as well as their use as pharmaceutical agents
12/01/1998US5843906 Meta-substituted phenylene sulphonamide derivatives
12/01/1998US5843904 Inhibitors of interleukin-1βconverting enzyme
12/01/1998US5843899 Use of insulin-like growth factors I and II for inhibition of inflammatory response
12/01/1998US5843719 Cellubrevin homolog
12/01/1998US5843474 Method of dialysis treatment, and dialysis apparatus related thereto
12/01/1998CA2054213C Inclusion complexes of 3-morpholino-sydnonimine or its salts or its tautomer isomer, process for the preparation thereof and pharmaceutical compositions containing the same
12/01/1998CA2018573C Lyophilized preparation of 6-(3-dimethylaminopropionyl) forskolin
11/1998
11/29/1998CA2233561A1 Novel compounds
11/29/1998CA2231723A1 Novel has2 splicing variant hoefc11: a target in chronic renal failure, inflammatory diseases and myocardial schemia
11/27/1998CA2232817A1 Novel compounds
11/26/1998WO1998053051A1 Short peptides which selectively modulate intracellular signalling
11/26/1998WO1998053050A2 Short peptides which selectively modulate the activity of serine/threonine kinases
11/26/1998WO1998052959A1 Novel glycosylated ginkgolide derivatives, their application as medicines and pharmaceutical compositions
11/26/1998WO1998052946A1 Azolidinediones useful for the treatment of diabetes, dyslipidemia and hypertension
11/26/1998WO1998052941A1 PYRAZOLE DERIVATIVES AS p38 KINASE INHIBITORS
11/26/1998WO1998052940A1 SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS
11/26/1998WO1998052937A2 4-aryl-3(5)-heteroaryl substituted pyrazoles as p38 kinase
11/26/1998WO1998052935A1 Substituted heterocyclic compounds, method for preparing and compositions containing same
11/26/1998WO1998052906A1 New nitromethyl ketones, process for preparing them and compositions containing them
11/26/1998WO1998052574A1 Vitamin d analogues and their neuronal effects
11/26/1998WO1998052568A1 THE USE OF 1,2,4-TRIAZOLO[1,5-c]PYRIMIDINE HETEROCYCLIC ANALOGUES FOR THE PREPARATION OF MEDICAMENTS USEFUL FOR THE TREATMENT OF CEREBROVASCULAR DISTURBANCES
11/26/1998WO1998052558A1 INHIBITION OF p38 KINASE ACTIVITY BY ARYL UREAS
11/26/1998WO1998052553A1 Methods for treatment of conditions associated with lactosylceramide
11/26/1998WO1998036733A3 Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blocker
11/26/1998DE19721099A1 Verwendung von Fumarsäurederivaten Use of fumaric acid derivatives
11/26/1998CA2291115A1 Substituted pyrazoles as p38 kinase inhibitors
11/26/1998CA2290831A1 New nitromethyl ketones, process for preparing them and compositions containing them
11/26/1998CA2290825A1 Short peptides which selectively modulate intracellular signalling
11/26/1998CA2290772A1 Vitamin d analogues and their neuronal effects
11/26/1998CA2290721A1 Short peptides which selectively modulate the activity of serine/threonine kinases
11/26/1998CA2289847A1 The use of 1,2,4-triazolo¬1,5-c|pyrimidine heterocyclic analogues for the preparation of medicaments useful for the treatment of cerebrovascular disturbances
11/26/1998CA2289594A1 Novel glycosylated ginkgolide derivatives, their application as medicines and pharmaceutical compositions
11/26/1998CA2288787A1 Pyrazole derivatives as p38 kinase inhibitors
11/26/1998CA2288741A1 4-aryl-3(5)-heteroaryl substituted pyrazoles as p38 kinase inhibitors
11/25/1998EP0879889A2 A novel member of the IL-1 family, IL-1 delta
11/25/1998EP0879888A2 Patched-2 polypeptides and polynucleotides and methods for their production
11/25/1998EP0879885A1 A novel human gene similar to a secreted murine protein sFRP-1
11/25/1998EP0879883A1 ATG-1120 (AIF-1-DELTA), a splice variant of AIF-1/RC-9
11/25/1998EP0879882A1 ATG-1100 (AIF-1-Gamma), a splice variant of AIF-1/RC-9
11/25/1998EP0879881A1 A human gene similar to a secreted protein frizb (ATG-1639)
11/25/1998EP0879880A1 ATG-1117 (AIF-3), a homolog of allograft inflammatory factor-1/RC-9
11/25/1998EP0879814A1 Triaromatic compounds, compositions containing them and uses thereof
11/25/1998EP0879298A2 Methods and compositions for diagnosis of hyperhomocysteinemia
11/25/1998EP0879286A1 Db, the receptor for leptin, nucleic acids encoding the receptor, and uses thereof
11/25/1998EP0879233A1 Chinoline and benzimidazole derivatives as bradykinin agonists
11/25/1998EP0879053A1 Use of an antagonist of ppar-alpha and ppar-gamma for the treatment of syndrom x
11/25/1998EP0654994B1 Use of cineol or menthol for the treament of asthma
11/25/1998EP0649303B1 Substituted arginines and substituted homoarginines and use thereof
11/25/1998EP0624159B1 Pyridyl substituted imidazoles
11/25/1998CN1200122A Lubeluzole N-oxide
11/25/1998CN1200120A Piperazino derivatives as neurokinin antagonists
11/25/1998CN1200035A Pharmaceutical compositions of levo-enantiomers of medetomidine derivatives and their use
11/25/1998CN1040873C Arylidene-1-azacycloalkanes and arylalkyl-1-azacycloalkanes, their salts, salts and composition and their application and producing process
11/24/1998US5840991 Antiatherosclerosis agents for lipid-lowering and antiperoxidative activity
11/24/1998US5840979 Useful in the treatment and prevention of diseases in which cell death occurs by apoptosis
11/24/1998US5840761 Antiarrhythmia agents, inhibitors of the cellular na+/h+ antiporter
11/24/1998US5840747 Calcium channel antagonists
11/24/1998US5840745 Hydrosoluble 3-arylidene-2-oxindole derivatives as tyrosine kinase inhibitors
11/24/1998US5840736 Methods and compositions for stimulating neurite growth
11/24/1998US5840722 Administering to inhibit endothelin receptors
11/24/1998US5840713 Therapy for tissue membrane insufficiency
11/24/1998US5840693 Vascular endothelial growth factor-B
11/24/1998US5840682 Peptide antagonists of neurotensin
11/24/1998US5840538 Lgt
11/24/1998US5840311 Administering hepatocyte growth factors to treat fibrosis disorder; increases collagenase activity
1 ... 1340 1341 1342 1343 1344 1345 1346 1347 1348 1349 1350 1351 1352 1353 1354 1355 1356 1357 1358 1359 1360 ... 1595